Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Dec. 31, 2018	Jun. 30, 2018
Current assets:
Cash	$ 159,671	$ 42,121
Accounts receivable, net	340,444	453,623
Inventory, net	580,475	531,249
Loan receivables	171,023	157,872
Other current assets	1,986,443	756,565
Total current assets	3,238,056	1,941,432
Equipment, net	255,755	195,180
Intangible Asset	11,900	12,600
Other assets	38,751	38,751
Total Assets	3,544,462	2,187,963
Current liabilities:
Note payable due to bank	25,982	25,982
Accounts payable and accrued liabilities	1,565,006	1,707,641
Customer deposits	210,535	329,509
Unearned revenue	20,798	110,142
Other payable	298,743	241,771
Accrued interest	567,209	493,365
Accrued compensation and personnel related payables	24,528	869,673
Note Payable	20,000	20,000
Notes payable - related parties	23,000	23,000
Loans payable	172,948	329,029
Loans payable - related party	55,634	30,000
Convertible notes payable, net	876,386	2,399,941
Derivative liabilities	1,734,338	3,069,616
Warrants liabilities	14,480	40,400
Shares to be issued	50,000	2,691,000
Total current liabilities	5,659,587	12,381,069
Total liabilities	5,659,587	12,381,069
Stockholders' deficiency:
Preferred stock ($0.001 par value, 10,000,000 shares authorized, 2,000,000 and 0 issued and outstanding at December 31, 2018 and June 30, 2018, respectively)	2,000
Common stock ($0.001 par value, 1,990,000,000 shares authorized, 637,860,318 and 246,135,203 shares issued and outstanding at December 31, 2018 and June 30, 2018, respectively)	637,861	246,136
Additional paid-in capital	58,747,248	21,952,560
Shares issued advance for Investment	(18,000,000)
Shares to Be Issued, Preferred Shares		2,000,000
Shares to Be Issued, Common Shares		467,996
Accumulated deficiency	(43,502,231)	(34,859,799)
Total stockholders' equity (deficiency)	(2,115,125)	(10,193,106)
Total liabilities and stockholders' equity (deficiency)	$ 3,544,462	$ 2,187,963